Clinical Trial Update: Clinical Study of U32 in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of the investigational agent U32 in patients with acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• U32

Snippet

Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Conditions: Acute Myeloid Leukaemia | Phase 1, Phase 2 | Status: RECRUITING